通过成像细胞计的多功能镜头在空间和时间中观察EGFR-HER2的交换激活 - - 针对性治疗的含义
László Ujlaky-Nagy1,2, János Szöllősi1,2, György Vereb1,2,3
1Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
概括
表皮生长因子受体 (EGFR) 和人类表皮生长因子受体2 (HER2) 的相互作用通过EGF结合得到增强,导致受体聚合. 这种动态行为可能会影响向癌症治疗的疗效.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 生物物理学的生物物理.
背景情况:
- 受体氨酸激酶 (RTK) 通过同型和异型二元化形成信号平台,对癌症进展至关重要.
- 皮表皮生长因子受体 (EGFR) 和人体皮表皮生长因子受体2 (HER2) 异构化在恶性瘤中至关重要,特别是在HER2过度表达的情况下.
- 乳腺瘤细胞系SK-BR-3,具有高HER2和中度EGFR表达,依赖于EGF驱动的HER2信号传递.
研究的目的:
- 为了研究EGF和HER2在细胞膜中的相互作用的时空动态,在EGF结合时.
- 了解连接体结合如何影响受体聚合和共扩散.
- 为提供有关向治疗的潜在成功的机制性见解,如pertuzumab.
主要方法:
- 通过光终身成像显微镜 (FLIM) 利用弗斯特共振能量转移 (FRET) 来评估分子近距离.
- 采用超分辨率空气扫描显微镜和光相关谱 (FCS/FCCS) 来分析受体聚合和扩散.
- 测量受体酸化作为EGF结合和交换活化的指标.
主要成果:
- 结合EGF证实了EGFR和HER2之间的联体增强相互作用,以及增加的HER2同类关联.
- 观察到HER2聚合和稳定共扩散的周期性增加,表明内部化和循环动态.
- 与EGFR和HER2的酸化相关的EGF结合和交易.
结论:
- 灵诱导的EGFR-HER2相互作用和随后的受体聚合表现出动态的时空模式.
- 受体聚合中的这些动态波动可能会为向异体化的抗体创造治疗窗口.
- 这些发现为 HER 针对家庭的治疗方法的有效性提供了机制性的见解.
关键词:
空气扫描显微镜的使用.这就是ErbB2的意思.光终身成像显微镜成像显微镜.福斯特共振能量转移的能量转移.在HER2中,HER2是HER2.同焦点显微镜的共焦显微镜.皮肤上生长因子受体.光相关性光谱学 光相关性光谱学光交叉相关性谱学 光交叉相关性谱学更多相关视频
08:29Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
55
08:26Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
24.8K
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
